Use of ghostwriters, guest authors appears frequent for studies involving rofecoxib
Apr 15, 2008 |
not rated yet |
0
An examination of medical articles about rofecoxib (a nonsteroidal anti-inflammatory drug) and court documents from litigation related to this product indicates that company employees or other unacknowledged authors were ...
Risk of death from rofecoxib in some trials may have been misrepresented by study sponsor
Apr 15, 2008 |
not rated yet |
0
A comparison of internal company documents, data submitted by the company to the FDA, and published clinical trial results indicates that the risk-benefit profile of rofecoxib in clinical trials involving patients with cognitive ...
